Atorvastatin reduces NF-κB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells
- 1 December 1999
- journal article
- research article
- Published by Elsevier BV in Atherosclerosis
- Vol. 147 (2), 253-261
- https://doi.org/10.1016/s0021-9150(99)00193-8
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Activation of NFκB Is Essential but Not Sufficient to Stimulate Mitogenesis of Vascular Smooth Muscle CellsBiochemical and Biophysical Research Communications, 1997
- The Nuclear Factor κ-B Signaling Pathway Participates in Dysregulation of Vascular Smooth Muscle Cells in Vitroand in Human AtherosclerosisJournal of Biological Chemistry, 1997
- Expression of a constitutive NF-kappa B-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells.JCI Insight, 1995
- Inhibition of NF-κB by Pyrrolidine Dithiocarbamate Blocks Endothelial Cell ActivationBiochemical and Biophysical Research Communications, 1995
- Lovastatin Inhibits Proliferation and Differentiation and Causes Apoptosis in Lipopolysaccharide-Stimulated Murine B CellsBiochemical and Biophysical Research Communications, 1995
- Function and Activation of NF-kappaB in the Immune SystemAnnual Review of Immunology, 1994
- HMG CoA reductase inhibitors. In vivo effects on carotid intimal thickening in normocholesterolemic rabbits.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Inhibition of cultured vascular smooth muscle cell migration by simvastatin (MK-733)Atherosclerosis, 1992
- A macrophage LPS-inducible early gene encodes the murine homologue of IP-10Biochemical and Biophysical Research Communications, 1990
- Regulation of the mevalonate pathwayNature, 1990